- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03737630
Inspiratory Muscle Training in Individuals With Cystic Fibrosis
April 14, 2020 updated by: Patri-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte
Effects of Inspiratory Muscle Training in Individuals Who Have Cystic Fibrosis
Cystic fibrosis is a genetic disease that affects some organs of the human body.
Among them, the lungs tend to be the most affected due to the accumulation of mucus in the airways, which in addition to avoiding the passage of air, favors pulmonary infections.
With the evolution of the condition, secondary complications arise, such as postural changes, decreased respiratory muscle strength, decreased functional capacity and, consequently, quality of life.
Therefore, respiratory muscle training may be an intervention that improves the respiratory condition of these individuals, allowing an improvement in the quality of life and may delay the evolution of respiratory symptoms.
Thus, this study aims to investigate a home protocol of respiratory muscle training on respiratory muscle strength, lung function, quality of life, posture and functional capacity in adolescents and adults with cystic fibrosis.
The researchers believe that the training can cause an improvement in the studied variables, and can be inserted in the usual treatment of these patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande Do Norte
-
Natal, Rio Grande Do Norte, Brazil
- Universidade Federal do Rio Grande do Norte
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 25 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of cystic fibrosis, confirmed by the sweat test;
- 14 - 25 years;
- Clinical stability;
- Absence of bacterial colonization for 4 weeks;
- Both sexes;
Exclusion Criteria:
- Inability to perform the protocol established by the study;
- Present any intercurrence during data collection;
- Being unable to understand and / or perform procedures.
- Colonization during study participation;
- Patient hospitalization due to worsening of the clinical picture.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: GExp
This group will perform the inspiratory muscle training with moderate load
|
This group will initiate inspiratory muscle training with 40% of the MIP load and each week will have a load increase of 10% of the initial MIP up to 4 weeks of training
|
ACTIVE_COMPARATOR: GCon
This group will initiate inspiratory muscle training with low load
|
This group will initiate inspiratory muscle training with 40% of the MIP load and each week will have a load increase of 10% of the initial MIP up to 4 weeks of training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Posture at 4 weeks
Time Frame: Baseline and after 4 weeks of training
|
Inclinometer Danoplus®
|
Baseline and after 4 weeks of training
|
Change from baseline Health-related quality of life at 4 weeks
Time Frame: Baseline and after 4 weeks of training
|
Health-related quality of life questionnaire (HRQoL)
|
Baseline and after 4 weeks of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Respiratory muscle strength at 4 weeks
Time Frame: Baseline and after 4 weeks of training
|
MVD300®
|
Baseline and after 4 weeks of training
|
Change from baseline Pulmonary function at 4 weeks
Time Frame: Baseline and after 4 weeks of training
|
Spirometry test using Koko® device
|
Baseline and after 4 weeks of training
|
Change from baseline Functional capacity at 4 weeks
Time Frame: Baseline and after 4 weeks of training
|
three-minute step test
|
Baseline and after 4 weeks of training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Victor Oliveira, Master, Universidade Federal do Rio Grande do Norte
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 5, 2019
Primary Completion (ACTUAL)
October 18, 2019
Study Completion (ACTUAL)
January 31, 2020
Study Registration Dates
First Submitted
November 6, 2018
First Submitted That Met QC Criteria
November 7, 2018
First Posted (ACTUAL)
November 9, 2018
Study Record Updates
Last Update Posted (ACTUAL)
April 16, 2020
Last Update Submitted That Met QC Criteria
April 14, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1a2b3c4d5e
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
AzurRx SASCompletedCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of PancreasTurkey, Hungary
-
Dartmouth-Hitchcock Medical CenterTrustees of Dartmouth CollegeWithdrawnCystic Fibrosis-related Diabetes | Cystic Fibrosis Liver Disease | CF - Cystic FibrosisUnited States
-
University Hospital, BordeauxCompleted
-
University of PortsmouthUniversity Hospital Southampton NHS Foundation Trust; Loughborough University; Queen Alexandra HospitalTerminated
Clinical Trials on Inspiratory muscle training
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
King Saud UniversityCompleted
-
Universidad Complutense de MadridColegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid,...CompletedQuality of Life | Covid19 | Respiratory Muscle Training | Respiratory Function Test | Psychosocial FactorSpain
-
Universidade do PortoUnknownMuscle Weakness | Dyspnea | Reactive Airways Dysfunction Syndrome (Disorder)Portugal
-
Gazi UniversityCompletedAllogeneic Hematopoietic Stem Cell Transplantation
-
Gazi UniversityCompleted
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreUnknownChronic Kidney Disease